Search Results 2691-2700 of 12430 for waardenburg syndrome

1. Central nervous system vascular malformations - Doctors and departments - Mayo Clinic

   ... disease, Moyamoya disease, Cerebral am...yloid angiopathy, Subarachnoid hemorrhage, Intracerebral hemorrhage, Brain aneurysm, Antiphospholipid syndrome ...

2. A Study to Evaluate the Safety and Effectiveness of RM-131 Administered to Patients with Vomiting Symptoms and Moderate to Severe Diabetes Caused Paralysis of the Stomach - Mayo Clinic

   The purpose of this study is to evaluate the effects of multiple dose regimens of RM-131 on vomiting episodes, stomach emptying and stomach paralysis symptoms ...

3. Familial adenomatous polyposis - Doctors and departments - Mayo Clinic

   Dan A. Schupack, M.D.. Gastroenterologist. Rochester, MN. Areas of focus: Colonoscopy, Upper endoscopy, Colon cancer, Lynch syndrome, Familial adenomatous ...

4. Publications - Rachael A. Vaubel, M.D., Ph.D. - Mayo Clinic

   Parkinson Disease. Mayo Clin Proc. 2016 Nov; 91 (11):e155-e156. View PubMed; Elsherif MA, Wenger DE, Vaubel RA, Spinner RJ. Nerve-Adherent Giant Cell Tumors ...

5. Mayo Clinic Biobank - Other Health Conditions

   D., is studying genetic factors that protect against Alzheimer's disease (AD) in a high-risk population. She has requested whole-exome sequencing data from 89 ...

6. Dementia - Doctors and departments - Mayo Clinic

   Researchers at Mayo Clinic are involved in the study of dementia and in improving diagnosis and treatment of the disorder. You might have access to a clinical ...

7. Parkinson's diagnosis is next challenge for endurance athlete - Mayo Clinic News Network

   I am Jamie Bryson. I just turned 40 years old in April of this year. In April of 2021, I was diagnosed with young-onset Parkinson's disease. I am an ...

8. STENOVA - A Study To Evaluate Safety, Tolerability, PK And PD Of AGMB-129 In Patients With Fibrostenotic Crohn's Disease - Mayo Clinic

   The goal of this clinical trial is to learn about the safety, pharmacokinetics and pharmacodynamics of AGMB-129 in patients with Crohn's disease. Participation ...

9. A Study To Compare The Effectiveness And Safety Of Emixustat Hydrochloride With Placebo To Treat Macular Atrophy Secondary To Stargadt Disease - Mayo Clinic

   ... disease (STGD). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.

10. Movement disorders - Doctors and departments - Mayo Clinic

    Movement disorder, Dystonia, NMDA receptor antibody encephalitis, Myelin oligodendrocyte glycoprotein antibody-associat...ed disease, Stiff person syndrome ...